Table 1. ARMS expression in primary cutaneous melanoma and metastatic melanoma (n=100).

	ARMS immunostain intensity
Lesion	n	Negative	Weak	Moderate	Strong	P-value a
Primary melanoma	54	3 (5.6%)	20 (37.0%)	21 (38.9%)	10 (18.5%)
Metastatic melanoma	46	6 (13.0%)	17 (37.0%)	14 (30.4%)	9 (19.6%)	0.58

Abbreviation: ARMS=ankyrin repeat-rich membrane spanning.

^aχ²-test.